A Case of Leukemic Pleural Infiltration in Atypical Chronic Myeloid Leukemia

Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.
Journal of Korean Medical Science (Impact Factor: 1.27). 11/2006; 21(5):936-9. DOI: 10.3346/jkms.2006.21.5.936
Source: PubMed


Pleural effusion in chronic myeloid leukemia (CML) is poorly understood and rarely reported in the literature. When the pleural effusion is caused by leukemic pleural infiltration, the differential white blood cell count of the effusion is identical to that of the peripheral blood, and the fluid cytology reveals leukemic blasts. We report here a case of bilateral pleural involvement of atypical CML in an 83-yr old male diagnosed with pancreatic cancer with abdominal wall metastasis and incidental peripheral leukocytosis. Based on bone marrow examination, chromosome analysis and polymerase chain reaction he was diagnosed with Philadelphia chromosome negative, BCR/ABL gene rearrangement negative CML. Following 3 months of treatment with gemcitabine for pancreatic cancer, he developed bilateral pleural effusions. All stages of granulocytes and a few blasts were present in both the pleural fluid and a peripheral blood smear. After treatment with hydroxyurea and pleurodesis, the pleural effusion resolved.

Download full-text


Available from: Jung-Shin Lee, Jan 03, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pleural effusions are a common problem in patients with malignancies. It can present as an isolated entity or be associated with parenchymal lung abnormalities. Patients with hematological malignancies (HM) can present with pleural effusion at diagnosis or may develop it during the course of their underlying disease. Regarding etiology, various causes can stimulate the accumulation of pleural fluid: the disease itself, drug toxicity, radiotherapy, underlying infections, secondary malignancies, autoimmunity, extramedullary hematopoiesis and other complications. Thoracentesis is a simple, safe and well-tolerated procedure in patients with HM.
    No preview · Article · Jan 2011
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pleural effusion in patients with chronic myeloid leukemia (CML) is very rare and poorly understood. We report here a 26-year-old male patient having CML and presenting with pleural effusion as the first clinical sign. The possible mechanism of pleural effusion in CML, the cytological interpretive problem and the clinical significance of finding immature leucocytes in pleural fluid are also briefly discussed.
    No preview · Article · Apr 2012 · Journal of Cytology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pulmonary manifestations have been well described in leukemia, but pleural disease is less common. This review highlights pleural effusions in acute and chronic leukemia and myelodysplastic syndrome (MDS) based on the evidence to date. Diagnostic workup and recommendations for the management of these effusions are also outlined. Pleural effusions in patients with leukemia are most often due to infection and to a lesser extent leukemic infiltration of the pleura. The prognostic implications of these effusions are unclear, but survival is most likely determined by the underlying malignancy and its response to treatment. New therapies have changed survival in these patients, and some of these treatments, such as tyrosine kinase inhibitors, have emerged as important causes for these effusions. Pleural interventions may be accomplished with few complications. Pleural effusions may occur with acute and chronic leukemia and MDS. Infection remains the most common cause. Malignant pleural effusions tend to occur in advanced disease in chronic leukemia, but they can be seen at any time with acute leukemia and MDS. With standard precautions, pleural procedures may be performed safely in this population. In cases of unclear cause, pleural and bone marrow biopsy should be considered.
    No preview · Article · May 2014 · Current opinion in pulmonary medicine